ID
15287
Description
Phase Ib Dose-escalation, Phase II Study of LEE011 and Letrozole for Treatment of Postmenopausal Women With Hormone Receptor Positive, HER2-negative, Advanced Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT02333370
Link
https://clinicaltrials.gov/show/NCT02333370
Keywords
Versions (1)
- 5/25/16 5/25/16 -
Uploaded on
May 25, 2016
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Hormone Receptor Positive, HER2-negative, Advanced Breast Cancer NCT02333370
Eligibility Hormone Receptor Positive, HER2-negative, Advanced Breast Cancer NCT02333370
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
CDK4/6 Inhibition
Data type
boolean
Alias
- UMLS CUI [1]
- C3899807
Description
Hypersensitivity LEE011 Excipient | Hypersensitivity letrozole Excipient
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0020517
- UMLS CUI [1,2]
- C2987342
- UMLS CUI [1,3]
- C0015237
- UMLS CUI [2,1]
- C0020517
- UMLS CUI [2,2]
- C0246421
- UMLS CUI [2,3]
- C0015237
Description
Inflammatory Breast Carcinoma
Data type
boolean
Alias
- UMLS CUI [1]
- C0278601
Description
Advanced breast cancer | Cancer treatment Systemic | Hormone Therapy | Chemotherapy
Data type
boolean
Alias
- UMLS CUI [1]
- C3495917
- UMLS CUI [2,1]
- C0920425
- UMLS CUI [2,2]
- C0205373
- UMLS CUI [3]
- C0279025
- UMLS CUI [4]
- C0392920
Description
Cancer treatment Other
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0920425
- UMLS CUI [1,2]
- C0205394
Description
major surgery | Investigational New Drugs | adverse effects Major
Data type
boolean
Alias
- UMLS CUI [1]
- C0679637
- UMLS CUI [2]
- C0013230
- UMLS CUI [3,1]
- C0001688
- UMLS CUI [3,2]
- C0205164
Description
Therapeutic radiology procedure
Data type
boolean
Alias
- UMLS CUI [1]
- C1522449
Description
Malignant Neoplasms
Data type
boolean
Alias
- UMLS CUI [1]
- C0006826
Description
CNS metastases
Data type
boolean
Alias
- UMLS CUI [1]
- C0686377
Description
HIV Infections
Data type
boolean
Alias
- UMLS CUI [1]
- C0019693
Description
Inclusion Other | Exclusion Criteria Other
Data type
boolean
Alias
- UMLS CUI [1,1]
- C1512693
- UMLS CUI [1,2]
- C0205394
- UMLS CUI [2,1]
- C0680251
- UMLS CUI [2,2]
- C0205394
Similar models
Eligibility Hormone Receptor Positive, HER2-negative, Advanced Breast Cancer NCT02333370
- StudyEvent: Eligibility
C3495949 (UMLS CUI [2,1])
C2945760 (UMLS CUI [2,2])
C3495917 (UMLS CUI [3,1])
C1522484 (UMLS CUI [3,2])
C1273390 (UMLS CUI [4])
C1511562 (UMLS CUI [5])
C1522449 (UMLS CUI [6])
C0344441 (UMLS CUI [2])
C1305671 (UMLS CUI [3])
C0031843 (UMLS CUI [1,2])
C0678852 (UMLS CUI [2])
C2987342 (UMLS CUI [1,2])
C0015237 (UMLS CUI [1,3])
C0020517 (UMLS CUI [2,1])
C0246421 (UMLS CUI [2,2])
C0015237 (UMLS CUI [2,3])
C0920425 (UMLS CUI [2,1])
C0205373 (UMLS CUI [2,2])
C0279025 (UMLS CUI [3])
C0392920 (UMLS CUI [4])
C0205394 (UMLS CUI [1,2])
C0013230 (UMLS CUI [2])
C0001688 (UMLS CUI [3,1])
C0205164 (UMLS CUI [3,2])
C0205394 (UMLS CUI [1,2])
C0680251 (UMLS CUI [2,1])
C0205394 (UMLS CUI [2,2])